54
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Studies on the Venom of Oxyuranus Microlepidotus

, , , &
Pages 373-385 | Published online: 25 Sep 2008
 

Abstract

The Australian Small-scaled Snake, Oxyuranus microlepidotus, recently rediscovered, is the world's most venomous snake, with a murine LD50 of 0.01 mg/kg. Recently developed immunological techniques, combined with a whole animal model, have enabled us to measure accurately the mass of venom actually injected by a striking snake. The venom of this species contains at least six identified protein fractions, and one or more of these possesses potent neurotoxic action. An initial assessment of the molecular weights of each of these is reported. This study describes field biting experiments applicable to potential human snake-bite, and presents data concerning the injected venomiLDso ratio which is an index of potential human lethality. This snake delivers an average mass of 17.3 mg in a strike, and the injected mass:. LD50 ratio is 1730, the highest recorded for any snake. Comparative results for five other Elapidae whose venom contains potent neurotoxins are also presented. An average mass of 0.6 mg of venom is spilt on the skin surface during a strike, and 40% of this can be recovered within three hours after a simulated bite. As with other Elapidae studied to date, an adequate mass of venom remains on the skin for an accurate species diagnosis to be made in the case of human snake-bite.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.